Is Glaxo killing HIV Babies?
Fintan Dunne – Research Kathy Mc Mahon / eionews.com 13dec00 Recent evidence indicates that Glaxo Wellcome’s anti-HIV drug AZT, may cause, rather than prevent Aids in babies. But this is not being disclosed to HIV+ mothers considering taking AZT in pregnancy. Earlier this year a study of over 400 infants born to HIV+ mothers in Miami-Dade, Florida, USA concluded that rapid progression to ‘full-blown’ Aids was “three times more likely to occur in infants born to [AZT] treated mothers -compared with findings in untreated mothers.” In fact, Figure 1 of the paper clearly shows a dose response curve. The earlier the mother began AZT treatment while pregnant, the sooner her HIV positive child got sick and died -compared with the HIV positive children born to HIV positive mothers who did not take AZT during pregnancy. Latest international research shows Glaxo Wellcome’s anti-HIV drug AZT Zidovudine (AZT, azidothymidine) may worsen Aids, can produce birth defects such as webbed hands and may c
